Skip to main content

We’re happy to announce Newswire has acquired HeadTalker!

From the beginning of HeadTalker, we have always placed the comments and happiness of our community first and we believe with this acquisition, we’ll continue to build out our vision for social media virality for brand campaigns as well as improving the opportunities to our user base.

Newswire and HeadTalker are committed to create new and better ways to take a social media message viral.

For now, HeadTalker with continue to function as it does today. Your Headtalker account and campaigns will continue as normal and we’ll be providing more details on upcoming plans for Headtalker in the coming weeks.

If you have any questions, please contact us.

Team HeadTalker and Newswire

New antivenin proof of concept

By Sy Hyett

Created 1 | Supported 10

31 of 25



Social Reach


Ended 07/01/2023

"Help me develop a new technique to produce vital antivenin that will save lives around the world."

— Sy Hyett and
other supporters

Share | How It Works | Embed

Snake bites kill at least 20,000 people every year worldwide; this number is estimated to be a lot higher (94,000) based on unreported bites. For many years antivenin has been the only effective treatment for venomous snake bites, saving thousands of lives every year. In 2010 the main antivenin used to treat African snake bites ceased production. This has left some of the poorest and most at-risk people in the world without an effective treatment for venomous snake bites. Remaining stocks of the required antivenin are dangerously depleted and now out of date.   I am developing a new, more productive and cheaper technique for the production of antivenin. This will enable the poorest people on the planet to get the treatment they require to save their lives.   Help me make a difference in the world!

No Campaign Updates. Check Back Sometime Soon.

Created on 2023-06-24 23:53:09